Khubieh J, Aherne G W, Chakraborty J
Biochemistry Department, University of Surrey, Guildford, U.K.
Cancer Chemother Pharmacol. 1990;26(5):330-2. doi: 10.1007/BF02897287.
A previously described radioimmunoassay (RIA) method for the measurement of 4-hydroxyandrostenedione (4-OHA) was used to investigate the serum drug levels attained after a single oral dose in male and female rats. Marked variability of serum drug concentrations and their time course were evident in male animals at all dose levels. In the female rat, in contrast, serum 4-OHA showed fewer individual differences, rose more rapidly and was sustained at substantially higher concentrations. In all animals, 4-OHA appeared in the serum within 0.5 h following the oral dose and persisted for at least 48 h. Doubling the dose from 8 mg/kg produced a disproportionately large elevation in serum drug levels, but a further increase to 32 mg/kg did not further increase serum levels.
采用先前描述的用于测量4-羟基雄烯二酮(4-OHA)的放射免疫测定(RIA)方法,研究雄性和雌性大鼠单次口服给药后达到的血清药物水平。在所有剂量水平下,雄性动物血清药物浓度及其时间进程存在明显差异。相比之下,雌性大鼠血清4-OHA个体差异较小,上升更快且维持在显著更高的浓度。在所有动物中,口服给药后0.5小时内血清中出现4-OHA,并持续至少48小时。将剂量从8mg/kg加倍导致血清药物水平不成比例地大幅升高,但进一步增加至32mg/kg并未进一步提高血清水平。